Member Info for Wiggly

No chance you will be able to buy at that price. Auction for first hour

Fair value based on the potential here has to be >£1b.

- A best in class LFT, now proven to have world leading S&S, coupled with multiple disclosed manufacturing partnerships and likely multiple undisclosed. To hit the market, at scale, in less than 5 weeks.

- A BAMS product that is being brought to market by a Billion Dollar GIANT, named Bruker

- AVA 6000 / Affimer to be tested in humans in the next few months. + Multiple follow on opportunities in this area.

- Multiple partnerships, such as Point, Astrea, Moderna and LG chem

- A JV whereby Venture capitalists have just pumped money in to drive it to the next level, at no cost to AVCT

Unbelievable JEFF!

Fireworks today

Going to be interesting for sure. Going to be a lot of very sick people this AM who ae currently out watching from the sidelines…

Talking of opening at 160??? I would be surprised if we open below 200. 300+ would not be a surprise but who knows - regardless, there is no way that I would sell, not with everything that is going to follow.

The news today is a game changer. It proves the Affimer tech and also proves we are very much on track to deliver a best in class, unbeatable LFT. This in itself is huge, but then we have all of the other non covid partnerships. Have said it many times but this is really a once in a lifetime opportunity to invest in a disruptive tech that is about to EXPLODE onto the market.

I assume that this will deliver 100% sensitivity and 100% specificity.

That Clinical validation has been taking place at 2 sites....EU... AND THE UK..

The initial evaluation of Avacta's lateral flow rapid antigen test with clinical samples has been carried out at two sites, one in EU and one in the UK using patient samples with viral loads confirmed by PCR

I bet you 100% SIR AL expected 100% Sensitivity and 100% specificity. Perfection has been the name of the game and SIr ALi has come bloody close.

HUGE VALIDATION of the Affimer Tech!

Today will be interesting.

WOW WOW WOW !!

WORLD BEST IN CLASS, GOLD STANDARD.

EVERYTHING, ALL OF THE TIE UPS, NOW MAKE 100% SENSE.

CONGRATS ALL

exactly - if the test is ready why would it be sent to Europe and not PD.

PS - the final test was sent to Europe many weeks ago (was held up in customs) so PD have very likely had our test for many weeks.

exactly - if the test is ready why would it be sent to Europe and not PD.

This is massive news. It proves there is nothing out there that has 'beaten' us and surely indicates IT IS US!!!

Daddypig - 100%. Those 'in the know' have clearly been buying AVCT in the knowledge that the final obstacle that could prevent the roll out of the Sovereign test has been overcome.

1005 leak now! Hold tight!

I expect the UK GOV LFT news next week and they will then reference during the roadmap / lockdown exit plan. They will not muddle the 2 and will generate maximum exposure to the LFT prior to the 22nd

yes, offering 148 for full holding. CLearly some increased demand / orders being worked.

note to MM - I aint selling until >>>>10.

After yesterdays premature ejaculation I think we are off and running now. do I hear a booom coming?

Hanoihank, if the Dx unit is delivering +500m revenue in 12-18 months I think that would be great. I think that is more than achievable. Where would that place the valuation today?

Question... if offered =>$500m for the Diagnostics arm would it be a sell or hold ?

IF the performance is truly outstanding as our CEO described...then the theory makes 100% sense.

Could be the reason why AS has refused to release any S&S data, citing 'Commercial Sensitivities' and why the UK Gov make no mention of our test - yet strangely the UK Gov and all UK LFT manufacturing capacity (BBI, Mologic, Abington, ODX) appear to be are gearing up to produce the Avacta test!

This is interesting/exciting and might well be one of the reasons why AVCT require strict NDAs. If the performance that the Affimer was capable of delivering had been verified public knowledge 4-5 months ago, AVCT would have been unable to achieve max value based on having close to ZERO revenues. Add in some massive contracts and the T/O value increases massively.